BackCisen Pharmaceutical , Ltd. Overview

Cisen Pharmaceutical , Ltd. Total Liabilities

Latest total liabilities for 603367.SS: $1.3B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$1.33B
↓ 6.80% YoYΔ $-97.01M vs prior year quarter

Peer trimmed avg / median

Loading

Cisen Pharmaceutical , Ltd. Total Liabilities History

Loading

Cisen Pharmaceutical , Ltd. vs. peers: Total Liabilities Comparison

Loading

Cisen Pharmaceutical , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cisen Pharmaceutical , Ltd. (603367.SS) FAQ

As of the most recent data (September 2026), 603367.SS shows a total liabilities of $1.3B. That compares with $1.4B in the prior-year period — down 6.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 603367.SS's total liabilities is now $1.3B (was $1.4B) — a 6.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cisen Pharmaceutical , Ltd. is outperforming or lagging.

Tracking 603367.SS's total liabilities over time shows whether Cisen Pharmaceutical , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3B That compares with $1.4B in the prior-year period — down 6.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Cisen Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $1.3B) with ownership activity and broader fundamentals.